Title | A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. |
Publication Type | Journal Article |
Year of Publication | 2003 |
Authors | Cong F, Zhang J, Pao W, Zhou P, Varmus H |
Journal | BMC Mol Biol |
Volume | 4 |
Pagination | 10 |
Date Published | 2003 Sep 29 |
ISSN | 1471-2199 |
Keywords | Animals, beta Catenin, Cell Division, Cell Line, Tumor, Colorectal Neoplasms, Cytoskeletal Proteins, Mice, Mice, Nude, Protein Engineering, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Signal Transduction, Trans-Activators, Ubiquitins, Wnt Proteins, Zebrafish Proteins |
Abstract | BACKGROUND: The Wnt signaling pathway plays critical roles in cell proliferation and cell fate determination at many stages of development. A critical downstream target of Wnt signaling is the cytosolic beta-catenin, which is stabilized upon Wnt activation and promotes transcription of a variety of target genes including c-myc and cyclin D. Aberrant Wnt signaling, which results from mutations of either beta-catenin or adenomatous polyposis coli (APC), renders beta-catenin resistant to degradation, and has been associated with multiple types of human cancers. RESULTS: A protein knockdown strategy was designed to reduce the cytosolic beta-catenin levels through accelerating its turnover rate. By engineering a chimeric protein with the beta-catenin binding domain of E-cadherin fused to betaTrCP ubiquitin-protein ligase, the stable beta-catenin mutant was recruited to the cellular SCF (Skp1, Cullin 1, and F-box-containing substrate receptor) ubiquitination machinery for ubiquitination and degradation. The DLD1 colon cancer cells express wild type beta-catenin at abnormally high levels due to loss of APC. Remarkably, conditional expression of betaTrCP-E-cadherin under the control of a tetracycline-repressive promoter in DLD1 cells selectively knocked down the cytosolic, but not membrane-associated subpopulation of beta-catenin. As a result, DLD1 cells were impaired in their growth and clonogenic ability in vitro, and lost their tumorigenic potential in nude mice. CONCLUSION: We have designed a novel approach to induce degradation of stabilized/mutated beta-catenin. Our results suggest that a high concentration of cytoplasmic beta-catenin is critical for the growth of colorectal tumor cells. The protein knockdown strategy can be utilized not only as a novel method to dissect the role of oncoproteins in tumorigenesis, but also as a unique tool to delineate the function of a subpopulation of proteins localized to a specific subcellular compartment. |
DOI | 10.1186/1471-2199-4-10 |
Alternate Journal | BMC Mol Biol |
PubMed ID | 14516475 |
PubMed Central ID | PMC222962 |
Grant List | R33 CA092792 / CA / NCI NIH HHS / United States 5R33-CA092792 / CA / NCI NIH HHS / United States |
Related Lab:
Related Faculty:
Pengbo Zhou, Ph.D.